EKF Diagnostics Investor Announcements
EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.
EKF Diagnostics Holdings plc is pleased to announce its final results for the year ended 31 December 2016.
EKF Diagnostics announces that it will release its preliminary results on 21 March 2017.
N+1 Singer appointed as Nominated Advisor and sole Broker.
Q4 trading materially higher than budget.
EKF Diagnostics Holdings plc announces that trading in Q3 of the current financial year was materially higher than budget and at a run-rate in excess of market forecasts.
EKF Diagnostics Holdings plc announces its unaudited interim results for the six months ended 30 June 2016, ahead of market expectations.